capecitabine has been researched along with Fecal Incontinence in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo, RO; Ferreira, CG; Guaraldi, S; Linhares, E; Martins, I; Thuler, LC; Torres, C; Valadão, M; Victorino, AP; Vieira, FM | 1 |
| Al-Najami, I; Cunningham, C; Jones, HJS | 1 |
| Hong, SM; Ihn, MH; Kang, SB; Kim, DW; Lee, SY; Oh, HK | 1 |
| Bateman, A; Brown, G; Chau, I; Cunningham, D; Giralt, J; Glimelius, B; Hickish, T; Keränen, SR; Oates, J; Peckitt, C; Sclafani, F; Tabernero, J; Tait, D; Thomas, J | 1 |
| Alqaisi, M; Bernal, P; Bush, D; Byrd, J; Garberoglio, C; Hussein, F; Malik, I | 1 |
3 trial(s) available for capecitabine and Fecal Incontinence
| Article | Year |
|---|---|
Quality of life in a randomized trial comparing two neoadjuvant regimens for locally advanced rectal cancer-INCAGI004.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Fecal Incontinence; Fluorouracil; Humans; Neoadjuvant Therapy; Quality of Life; Rectal Neoplasms | 2022 |
Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cetuximab; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Fecal Incontinence; Health Status; Humans; Magnetic Resonance Imaging; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Quality of Life; Rectal Neoplasms; Rectum; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires | 2015 |
A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Celecoxib; Deoxycytidine; Diarrhea; Fecal Incontinence; Female; Fluorouracil; Gangrene; Gastrointestinal Diseases; Humans; Irinotecan; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Proctitis; Pyrazoles; Radiation Injuries; Radiation-Sensitizing Agents; Rectal Neoplasms; Sulfonamides | 2010 |
2 other study(ies) available for capecitabine and Fecal Incontinence
| Article | Year |
|---|---|
Quality of life after rectal-preserving treatment of rectal cancer.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Defecation; Dyspareunia; Erectile Dysfunction; Fecal Incontinence; Female; Gastrointestinal Hemorrhage; Humans; Lower Urinary Tract Symptoms; Male; Neoadjuvant Therapy; Organ Sparing Treatments; Proctectomy; Quality of Life; Rectal Neoplasms; Sexual Dysfunction, Physiological; Watchful Waiting | 2020 |
Risk factors for bowel dysfunction after sphincter-preserving rectal cancer surgery: a prospective study using the Memorial Sloan Kettering Cancer Center bowel function instrument.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Chemoradiotherapy; Deoxycytidine; Fecal Incontinence; Female; Fluorouracil; Humans; Ileostomy; Irinotecan; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Postoperative Complications; Prospective Studies; Rectal Neoplasms; Risk Factors; Surveys and Questionnaires; Tomography, X-Ray Computed; Treatment Outcome | 2014 |